FDA Inspection
Fenwal International, Inc.Fenwal International, Inc. – FDA Inspection, Feb 5, 2026
Record Details
This FDA Inspection record concerns Fenwal International, Inc., with an inspection on February 5, 2026, issued by the San Juan District Office, covering biologics.
View Company Profile
ID · b85e638e-4ee0-4b48-91c7-ed126042669d
Inspection Facts
- Inspection number
- 1294942
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
9- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.100(b)SOPs not followed / documented
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.180(e)(1)Representative Number of Batches for Annual Review
- 21 CFR 211.22(a)Authority lacking to review records, investigate errors
- 21 CFR 211.42(c)(5)Mfg / Processing Operations Area
- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.65(a)Equipment construction - reactive surfaces
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fenwal International, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2024 | VAI | San Juan District Office | Blood and Blood Products |
| September 24, 2022 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 24, 2021 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 26, 2019 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 22, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fenwal International, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.